Cerebrospinal fluid glutamate levels in chronic migraine

scientific article

Cerebrospinal fluid glutamate levels in chronic migraine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1468-2982.2004.00750.X
P698PubMed publication ID15315529
P5875ResearchGate publication ID8395076

P2093author name stringPeres MF
Zukerman E
Alonso EO
Faulhaber MH
Senne Soares CA
Santos BF
P2860cites workThe American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria CommitteeQ29618782
Chronic daily headacheQ33952713
Deconstructing migraine headache into peripheral and central sensitizationQ34134608
Cerebrospinal fluid analyses in migraine patients and controlsQ34733869
Fibromyalgia, fatigue, and headache disordersQ35065211
Why headache treatment failsQ35101920
Central sensitization in fibromyalgia and other musculoskeletal disordersQ35208440
Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluidQ44380439
Platelet Glycine, Glutamate and Aspartate in Primary HeadacheQ46199099
Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampusQ48210073
Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neuronsQ48490006
Fibromyalgia is common in patients with transformed migraineQ48682127
Neuroexcitatory plasma amino acids are elevated in migraineQ48893091
The impact of migraine on quality of life in the general population: the GEM study.Q51974172
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectcerebrospinal fluidQ54196
migraineQ133823
P1104number of pages5
P304page(s)735-739
P577publication date2004-09-01
P1433published inCephalalgiaQ5063251
P1476titleCerebrospinal fluid glutamate levels in chronic migraine
P478volume24

Reverse relations

cites work (P2860)
Q37409505Allodynia in migraine: frequent random association or unavoidable consequence?
Q36853404Altered kynurenine pathway metabolites in serum of chronic migraine patients
Q38121110Biomarkers associated with migraine and their potential role in migraine management
Q34154494Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.
Q36546364Cerebrospinal fluid biomarkers in primary headache disorders
Q37363477Chronic migraine: current pathophysiologic concepts as targets for treatment
Q55119772Comparison of Pregabalin and Sodium Valproate in Migraine Prophylaxis: A Randomized Double-Blinded Study.
Q35374174Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems
Q46146404Effective prophylactic treatments of migraine lower plasma glutamate levels
Q37579465Electroacupuncture at Acupoints Reverses Plasma Glutamate, Lipid, and LDL/VLDL in an Acute Migraine Rat Model: A (1) H NMR-Based Metabolomic Study
Q33684257Elevated insular glutamate in fibromyalgia is associated with experimental pain
Q37271327Excitatory neurotransmitters in brain regions in interictal migraine patients
Q38601633Fibromyalgia: A Critical and Comprehensive Review
Q37258900Fibromyalgia: an update and immunological aspects
Q94460429From transformation to chronification of migraine: pathophysiological and clinical aspects
Q28249721Future drugs for migraine
Q50689549Genetic analysis of GRIA2 and GRIA4 genes in migraine.
Q35658661Genotype-phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1.
Q52672731Glutamate and Its Receptors as Therapeutic Targets for Migraine.
Q43358780Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients
Q92056807Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia
Q38346851Headache research and medical practice in Brazil: an historical overview.
Q33812736Headache-type adverse effects of NO donors: vasodilation and beyond
Q46639229Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1.
Q36405681Intravenous treatment of chronic daily headaches in the outpatient headache clinic
Q34317484Kynurenines in the CNS: recent advances and new questions.
Q35578143Large-scale mass spectrometry imaging investigation of consequences of cortical spreading depression in a transgenic mouse model of migraine.
Q51010531Migraine and cognition in children: a controlled study.
Q58867807Migraine and motion sickness independently contribute to visual discomfort
Q28078828Molecular factors in migraine
Q37258906Neuromodulators for the treatment of headache disorders and fibromyalgia
Q92126278Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain
Q35722682PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling
Q37750554Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond
Q38016505Pathogenesis of migraine: role of neuromodulators
Q35539662Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache
Q51181390Reduced urinary glutamate levels are associated with the frequency of migraine attacks in females.
Q47415985Salivary glutamate is elevated in individuals with chronic migraine.
Q36951346Sensitization, glutamate, and the link between migraine and fibromyalgia
Q36961660Survey of ALS-associated factors potentially promoting Ca2+ overload of motor neurons
Q33794568The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat.
Q26745558The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence
Q84199783[Chronic cluster headache : how much does treatment cost?]
Q53067651[Pain perception of adolescents with chronic functional pain : adaptation and psychometric validation of the Pain Perception Scale (SES) by Geissner].
Q86695252[Update on trigeminal autonomic cephalalgia]

Search more.